AzTrials
AzTrials

Acute PainPhase 2AcuMAPNCT02460913

Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department

A Phase 2 study testing Acupuncture and Morphine titration in people with Acute Pain, run by University of Monastir.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Inadequate pain management is a common problem encountered in ED settings. Pain relief medications use is often limited by their side effects. Evidence suggests that non pharmacologic pain relief techniques such as acupuncture can play a central role to treat pain in acute conditions, but their application is still… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Pain
What is being tested?
Acupuncture and Morphine titration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
No sites listed yet
Study dates
Apr 2012to Mar 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Acute onset pain < 72 hours of the ED presentation
  • Pain intensity ≥ 40 of the VAS or NRS (ranging from 0 for no pain to 100 for maximum imaginable pain)
  • Acute musculoskeletal pain with no evidence of fracture or dislocation, including ankle and knee sprains without signs of severity (ligament rupture, laxity), shoulder and elbow tendinitis, upper and lower limb mechanical pains and lower back pain with no evidence of neurological deficit.
  • Acute abdominal pain with no urging surgical intervention including renal colic and dysmenorrhea.
  • Acute headache that meets the criteria of primary headache, as described by the international headache society.

Who cannot join

  • Temperature > 37.7°c
  • Violent mechanism of trauma
  • Patients under anticoagulant drugs or with coagulation abnormalities
  • Skin affections (infections, hematoma, dermatosis) that would impair the use of certain acupuncture points
  • Patients that were judged enable to participate in the study at the discretion of the treating physician.
  • Refusal, inability to consent.
Show all 11Show fewer
  • Inability to assess the degree of pain using the VAS or NRS
  • Patients who had received analgesics in the 6 hours prior to the enrollment
  • An initial pain score ≤ 40 on the VAS or NRS
  • Patients who had presented to the ED in the last 24 hours with the same motif
  • Pregnancy

About this study

Official title: Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department. An Efficacy and Safety Study

Inadequate pain management is a common problem encountered in ED settings. Pain relief medications use is often limited by their side effects. Evidence suggests that non pharmacologic pain relief techniques such as acupuncture can play a central role to treat pain in acute conditions, but their application is still scarce.

Read the detailed description

Pain is a common cause of emergency department visits and its control remains a challenge and health priority worldwide. Many techniques were developed to control pain and to ensure patients comfort but their application is still difficult especially in emergency department (ED) settings, due to the variety of treated conditions, the non-availability of qualified practitioners and the patient's specificity. Pharmacologic methods in particular IV opioids are the most used and with regard to their rapid action with high efficacy. But the use of these drugs can be limited by their side effects. Non-pharmacologic pain relief techniques such as acupuncture have been proposed. During the second half of the twentieth century, acupuncture was established in Europe and in the last two decades, it has spread around the world. In Tunisia, acupuncture was introduced into the health system in the 90s, particularly to treat pain.

The World Health Organization (WHO) has recognized acupuncture as safe and sound therapy. A preliminary list of acupuncture indications has been reported including 43 diseases. However, the introduction of acupuncture in the treatment of pain in ED is more recent or even anecdotal. In the treatment of chronic pain, it was shown that acupuncture is comparable to morphine and that its better safety profile makes it the method of choice in some clinical conditions.

In a recent systematic review, it has been concluded that there is insufficient evidence for the use of acupuncture in the ED settings due to the paucity of randomized controlled trials and the suboptimal methodological qualities of related studies.

The aim of our study was to evaluate the efficacy and safety of acupuncture compared with morphine for the management of acute pain in ED.

Conditions
Acute Pain
Being tested
Acupuncture, Morphine titration
Keywords
acupuncture, morphine, acute pain
Medical subject headings
Acute Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AcupunctureProcedure or surgery

    Acupuncture session of 20 to 30 minutes. Treatment protocols were determined through review of major clinical manuals and textbooks, literature review, and a panel of specialist acupuncturists from Chinese medicine backgrounds.

  • Morphine titrationDrug

    Also called Morphine

    Patients in this group received IV titrated morphine. Morphine was prepared onsite and diluted in a manner to obtain a dose of 1mg in each ml of normal saline. The initial dose was 0.1 mg per kg and a titration dose of 0.05 mg per Kg was repeated every 5 minutes until reaching objective. The maximum allowed dose was 1.5 mg/kg.

Study groups in NCT02460913
Study groupRoleWhat they receive
AcupunctureExperimentalpatients received a 20 to 30 minutes session of acupuncture
Receives: Procedure: Acupuncture
IV MorphineActive comparatorpatients received an intravenous titration of morphine every 5 minutes.
Receives: Drug: Morphine titration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change of pain severity from baseline

    Change of pain score was assessed at 10, 20, 30, 45 and 60 minutes time points from the starting of the protocol.

    Pain severity was measured using the visual analogic scale (VAS) going from 10 (maximum imaginable pain) to 0 (no pain). if the VAS was not applicable to certain patients, a verbal numeric rating scale (NRS) was used instead.

    Success of treatment was defined by a drop in the pain intensity under 30.

    Measured: 10, 20, 30, 45, 60 minutes

Secondary outcomes (2)
  1. resolution time

    This interval was defined by the time (in minutes) elapsed between the start of the protocol (T0) and the decrease of the pain score of at least 50% of its initial value.

    Measured: 10, 20, 30, 45, 60 minutes

  2. adverse events

    Occurrence of major side effects implicates the immediate ending of the protocol, more particularly:

    • Allergic manifestations such as rush and generalized edema
    • severe hypotension defined by a drop of the systolic blood pressure under 90 mmHg or a loss of more than 20 mmHg of the initial systolic blood pressure
    • recurrent vomiting non controlled by the standard measures
    • Altered mental status
    • Uncontrolled bleeding from the site of needle insertion
    • Respiratory distress with capillary saturation under 95% or signs of pneumothorax

    Measured: 10, 20, 30, 45, 60 minutes and until ED discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2015 (estimated)
  2. Study startApr 2012
  3. Primary completionMar 2013
  4. Study completionMar 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02460913
Sponsor's protocol ID
13/02
Acronym
AcuMAP
Status last verified
Feb 2020
First submitted
25 May 2015
Last updated
21 Feb 2020
Results posted
No
Data monitoring committee
No

Publications

  • Kim KH, Lee BR, Ryu JH, Choi TY, Yang GY. The role of acupuncture in emergency department settings: a systematic review. Complement Ther Med. 2013 Feb;21(1):65-72. doi: 10.1016/j.ctim.2012.12.004. Epub 2012 Dec 29.

    PubMed 23374207
  • Cohen M, Parker S, Taylor D, Smit de V, Ben-Meir M, Cameron P, Xue C. Acupuncture as analgesia for low back pain, ankle sprain and migraine in emergency departments: study protocol for a randomized controlled trial. Trials. 2011 Nov 15;12:241. doi: 10.1186/1745-6215-12-241.

    PubMed 22085683

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Acupuncture and Morphine titration in people with Acute Pain, run by University of Monastir.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change of pain severity from baseline (time frame: 10, 20, 30, 45, 60 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02460913, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in